238 related articles for article (PubMed ID: 29932071)
1. A study on the genotype frequency of -158 Gγ (C→T)
Moez P; Moftah R; Mahmoud HA
J Genet; 2018 Jun; 97(2):505-511. PubMed ID: 29932071
[TBL] [Abstract][Full Text] [Related]
2. Association between BCL11A, HSB1L-MYB, and XmnI γG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.
El-Ghamrawy M; Yassa ME; Tousson AMS; El-Hady MA; Mikhaeil E; Mohamed NB; Khorshied MM
Ann Hematol; 2020 Oct; 99(10):2279-2288. PubMed ID: 32772141
[TBL] [Abstract][Full Text] [Related]
3. Association of Xmn1 -158 γG variant with severity and HbF levels in β-thalassemia major and sickle cell anaemia.
Dadheech S; Jain S; Madhulatha D; Sharma V; Joseph J; Jyothy A; Munshi A
Mol Biol Rep; 2014 May; 41(5):3331-7. PubMed ID: 24488321
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of haemoglobin S in the closed Egyptian community of Siwa Oasis.
Moez P; Younan DN
J Clin Pathol; 2016 Jul; 69(7):632-6. PubMed ID: 26658219
[TBL] [Abstract][Full Text] [Related]
5. Association Between Selected Single Nucleotide Polymorphisms in Globin and Related Genes and Response to Hydroxyurea Therapy in Ghanaian Children with Sickle Cell Disease.
Manu GP; Segbefia C; N'guessan BB; Coffie SA; Adjei GO
Pharmgenomics Pers Med; 2022; 15():205-214. PubMed ID: 35300055
[TBL] [Abstract][Full Text] [Related]
6. Frequency of Gγ-globin promoter -158 (C>T) XmnI polymorphism in patients with homozygous/compound heterozygous beta thalassaemia.
Ali N; Ayyub M; Khan SA; Ahmed S; Abbas K; Malik HS; Tashfeen S
Hematol Oncol Stem Cell Ther; 2015 Mar; 8(1):10-5. PubMed ID: 25591326
[TBL] [Abstract][Full Text] [Related]
7. Modulating Effect of the -158 γ (C→T) Xmn1 Polymorphism in Indian Sickle Cell Patients.
Pandey S; Pandey S; Mishra RM; Saxena R
Mediterr J Hematol Infect Dis; 2012; 4(1):e2012001. PubMed ID: 22348183
[TBL] [Abstract][Full Text] [Related]
8. Association between XmnI Polymorphism and HbF Level in Sickle Cell Disease Patients from Chhattisgarh.
Bhagat S; Patra PK; Thakur AS
Int J Biomed Sci; 2012 Mar; 8(1):36-9. PubMed ID: 23675255
[TBL] [Abstract][Full Text] [Related]
9.
Alaoui-Ismaili FZ; Laghmich A; Ghailani-Nourouti N; Barakat A; Bennani-Mechita M
Hemoglobin; 2020 May; 44(3):190-194. PubMed ID: 32508152
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and Impact of HMOX1 Polymorphism (rs2071746: A > T) in Indian Sickle Cell Disease Patients.
Pandey H; Singh K; Ranjan R; Dass J; Tyagi S; Seth T; Saxena R; Mahapatra M
J Lab Physicians; 2023 Dec; 15(4):583-589. PubMed ID: 37780888
[No Abstract] [Full Text] [Related]
11. The Xmn1 polymorphic site 5' to the (G)gamma gene and its correlation to the (G)gamma:(A)gamma ratio, age at first blood transfusion and clinical features in beta-thalassemia patients from Western Iran.
Nemati H; Rahimi Z; Bahrami G
Mol Biol Rep; 2010 Jan; 37(1):159-64. PubMed ID: 19444645
[TBL] [Abstract][Full Text] [Related]
12. CD209-336A/G promotor polymorphism and its clinical associations in sickle cell disease Egyptian Pediatric patients.
Afifi RA; Kamal D; Sayed RE; Ekladious SMM; Shaheen GH; Yousry SM; Hussein RE
Hematol Oncol Stem Cell Ther; 2018 Jun; 11(2):75-81. PubMed ID: 29100978
[TBL] [Abstract][Full Text] [Related]
13. rs11886868 and rs4671393 of BCL11A associated with HbF level variation and modulate clinical events among sickle cell anemia patients.
Chaouch L; Moumni I; Ouragini H; Darragi I; Kalai M; Chaouachi D; Boudrigua I; Hafsia R; Abbes S
Hematology; 2016 Aug; 21(7):425-9. PubMed ID: 27077760
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Xmnl Gγ polymorphism in Egyptian patients with β-thalassemia major.
Tantawy AA; Andrawes NG; Ismaeil A; Kamel SA; Emam W
Ann Saudi Med; 2012; 32(5):487-91. PubMed ID: 22871617
[TBL] [Abstract][Full Text] [Related]
15. Molecular Analysis of Xmn1-Polymorphic Site ´5 to G
Elderdery AY; Alsrhani A; Alzahrani B; Atif M; Refaiy AI; Shiwani H; Abbas A; Yahia DA
Evid Based Complement Alternat Med; 2022; 2022():1717207. PubMed ID: 35356246
[TBL] [Abstract][Full Text] [Related]
16. DNA polymorphisms at BCL11A, HBS1L-MYB and Xmn1-HBG2 site loci associated with fetal hemoglobin levels in sickle cell anemia patients from Northern Brazil.
Cardoso GL; Diniz IG; Silva AN; Cunha DA; Silva Junior JS; Uchôa CT; Santos SE; Trindade SM; Cardoso Mdo S; Guerreiro JF
Blood Cells Mol Dis; 2014 Dec; 53(4):176-9. PubMed ID: 25084696
[TBL] [Abstract][Full Text] [Related]
17. Xmn1-G γ polymorphism and clinical predictors of severity of disease in β-thalassemia intermedia.
Oberoi S; Das R; Panigrahi I; Kaur J; Marwaha RK
Pediatr Blood Cancer; 2011 Dec; 57(6):1025-8. PubMed ID: 21755589
[TBL] [Abstract][Full Text] [Related]
18. Association of C3435T, C1236T and C4125A Polymorphisms of the MDR-1 Gene in Egyptian Children with Acute Lymphoblastic Leukaemia.
Talaat RM; Y K El-Kelliny M; El-Akhras BA; Bakry RM; Riad KF; Guirgis AA
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2535-2543. PubMed ID: 30256048
[TBL] [Abstract][Full Text] [Related]
19. Implication of HMOX1 and CCR5 genotypes on clinical phenotype of Egyptian patients with sickle cell anemia.
Bakr S; Khorshied M; Talha N; Jaffer KY; Soliman N; Eid K; El-Ghamrawy M
Ann Hematol; 2019 Aug; 98(8):1805-1812. PubMed ID: 31030250
[TBL] [Abstract][Full Text] [Related]
20. Thrombin activatable fibrinolysis inhibitor plasma levels and TAFI Thr325Ile genetic polymorphism in a cohort of Egyptian sickle cell disease patients and impact on disease severity.
Hamdy M; Shaheen IA; Khallaf M; Selim YMM
Pediatr Blood Cancer; 2024 Jun; 71(6):e30959. PubMed ID: 38520679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
